SpectraScience, Inc. (OTCQB: SCIE) (PINKSHEETS: SCIE), a San Diego
based medical device company, today announced that Chief Executive
Officer Michael Oliver will present to investors as part of the LHA
Life Sciences & Medical Technologies Virtual Conference on Thursday,
February 16, 2012, at Noon Eastern time.
A webcast of the presentation will be accessible online at the
PrecisionIR event site:
An archived version will be available for 30 days.
About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that
designs, develops, manufactures and markets light-based analysis
systems capable of determining whether tissue is normal, pre-cancerous
or cancerous without physically removing tissue from the body. The
WavSTAT Optical Biopsy System uses light to optically diagnose tissue
and provide the physician with an immediate analysis. With FDA
approval for sale in the U.S. and the CE Mark for the European Union,
the WavSTAT System is the first commercially available product that
incorporates this innovative technology for clinical use.